391 related articles for article (PubMed ID: 29051464)
21. Use of zebrafish larvae lateral line to study protection against cisplatin-induced ototoxicity: A scoping review.
Domarecka E; Skarzynska M; Szczepek AJ; Hatzopoulos S
Int J Immunopathol Pharmacol; 2020; 34():2058738420959554. PubMed ID: 33084473
[TBL] [Abstract][Full Text] [Related]
22. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
23. A combinatorial approach to protect sensory tissue against cisplatin-induced ototoxicity.
Febles NK; Bauer MA; Ding B; Zhu X; Gallant ND; Frisina RD
Hear Res; 2022 Mar; 415():108430. PubMed ID: 35051751
[TBL] [Abstract][Full Text] [Related]
24. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.
Sheth S; Mukherjea D; Rybak LP; Ramkumar V
Front Cell Neurosci; 2017; 11():338. PubMed ID: 29163050
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of intratympanic infiltration of N-acetyl cysteine in cisplatin ototoxicity].
Rosas-Gutiérrez GDC; Fernández-Hernández JP; Olea-González AI
Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S318-S322. PubMed ID: 38016189
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
Fetoni AR; Paciello F; Troiani D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
[No Abstract] [Full Text] [Related]
28. Local Drug Delivery for Prevention of Hearing Loss.
Rybak LP; Dhukhwa A; Mukherjea D; Ramkumar V
Front Cell Neurosci; 2019; 13():300. PubMed ID: 31338024
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of cisplatin-induced ototoxicity and prevention.
Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
[TBL] [Abstract][Full Text] [Related]
30. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity.
Özel HE; Özdoğan F; Gürgen SG; Esen E; Genç S; Selçuk A
J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667
[TBL] [Abstract][Full Text] [Related]
33. Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy.
Cortés Fuentes IA; Burotto M; Retamal MA; Frelinghuysen M; Caglevic C; Gormaz JG
Free Radic Biol Med; 2020 Nov; 160():263-276. PubMed ID: 32827639
[TBL] [Abstract][Full Text] [Related]
34. Protective role of misoprostol against cisplatin-induced ototoxicity.
Doğan M; Polat H; Yaşar M; Kaya A; Bayram A; Şenel F; Özcan İ
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3685-3692. PubMed ID: 27052552
[TBL] [Abstract][Full Text] [Related]
35. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
36. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
37. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.
Brock PR; Knight KR; Freyer DR; Campbell KC; Steyger PS; Blakley BW; Rassekh SR; Chang KW; Fligor BJ; Rajput K; Sullivan M; Neuwelt EA
J Clin Oncol; 2012 Jul; 30(19):2408-17. PubMed ID: 22547603
[TBL] [Abstract][Full Text] [Related]
38. Oxytocin as a protective agent in cisplatin-induced ototoxicity.
Bekmez Bilmez ZE; Aydin S; Şanli A; Altintoprak N; Demir MG; Atalay Erdoğan B; Kösemihal E
Cancer Chemother Pharmacol; 2016 Apr; 77(4):875-9. PubMed ID: 26865281
[TBL] [Abstract][Full Text] [Related]
39. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
Sarafraz Z; Ahmadi A; Daneshi A
Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
[TBL] [Abstract][Full Text] [Related]
40. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
Saliba I; El Fata F; Ouelette V; Robitaille Y
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
